Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term growth in children with atopic dermatitis treated with tacrolimus and hydrocortisone-17-butyrate
2004-004052-39Phase 4Completed
- Sponsor
- Children's Clinic Randers
- Start
- Oct 2004
- Modality
- Small Molecules, RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tacrolimus and hydrocortisone butyrate in atopic dermatitis (AD) (2 arms), sponsored by Children's Clinic Randers. Primary endpoint: Mean lower leg growth rates. Started Oct 2004; status: completed.
02
Drugs
tacrolimushydrocortisone butyrate
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2004-004052-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004052-39.